TY - JOUR
T1 - ESHRE PGD Consortium data collection V: Cycles from January to December 2002 with pregnancy follow-up to October 2003
AU - Harper, J. C.
AU - Boelaert, K.
AU - Geraedts, J.
AU - Harton, G.
AU - Kearns, W. G.
AU - Moutou, C.
AU - Muntjewerff, N.
AU - Repping, S.
AU - SenGupta, S.
AU - Scriven, P. N.
AU - Traeger-Synodinos, J.
AU - Vesela, K.
AU - Wilton, L.
AU - Sermon, K. D.
PY - 2006
Y1 - 2006
N2 - The fifth report of the ESHRE PGD Consortium is presented (data collection V). For the first time, the cycle data were collected for one calendar year (2002) in the following October, so that data collection was complete for pregnancies and babies. The data were collected using a Filemaker Pro database and divided into referrals, cycles, pregnancies and babies. There are currently 66 active centres registered with the consortium; however, the data presented here were obtained from 43 centres and included 1603 referrals, 2219 cycles, 485 pregnancies and 382 babies born. The cycle data were divided into preimplantation genetic diagnosis (PGD) for inherited disorders (including chromosome abnormalities, sexing for X-linked disease and monogenic disorders), aneuploidy screening (PGS) and the use of PGD for social sexing. Data collection V is compared with the previous cumulative data collection (I-IV), which comprised 4058 PGD/PGS cycles that reached oocyte retrieval
AB - The fifth report of the ESHRE PGD Consortium is presented (data collection V). For the first time, the cycle data were collected for one calendar year (2002) in the following October, so that data collection was complete for pregnancies and babies. The data were collected using a Filemaker Pro database and divided into referrals, cycles, pregnancies and babies. There are currently 66 active centres registered with the consortium; however, the data presented here were obtained from 43 centres and included 1603 referrals, 2219 cycles, 485 pregnancies and 382 babies born. The cycle data were divided into preimplantation genetic diagnosis (PGD) for inherited disorders (including chromosome abnormalities, sexing for X-linked disease and monogenic disorders), aneuploidy screening (PGS) and the use of PGD for social sexing. Data collection V is compared with the previous cumulative data collection (I-IV), which comprised 4058 PGD/PGS cycles that reached oocyte retrieval
U2 - https://doi.org/10.1093/humrep/dei292
DO - https://doi.org/10.1093/humrep/dei292
M3 - Article
C2 - 16172150
SN - 0268-1161
VL - 21
SP - 3
EP - 21
JO - Human reproduction (Oxford, England)
JF - Human reproduction (Oxford, England)
IS - 1
ER -